OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
This is a hybrid seminar, in person in the Richard Doll Building and via Zoom.
To join via Zoom, please register in advance for this meeting:
us06web.zoom.us/meeting/register/jJbHX8gQRiSlYH6f2pst7w
After registering, you will receive a confirmation email containing information about joining the meeting.
Speaker Bio: Prof Katie Flanagan is a clinician scientist based in Australia. She is a Professor at RMIT University and University of Tasmania, Director of Infectious Diseases at Launceston General Hospital and Director of the Tasmanian Vaccine Trial Centre. She is a member of the Australian Technical Advisory Group on Immunisation and Past President of the Australasian Society for Infectious Diseases. She completed a PhD in malaria immunology in Adrian Hill’s group in 2000 and has >25 years’ experience conducting vaccine research globally. Her current main research focus involves applying systems biology techniques to study human responses to vaccination, particularly at the extremes of age and pregnancy; and the role that biological sex plays in the vaccine-specific responses and non-targeted effects of vaccines.
